ストックスクリーナーアプリを入手
15.21
3.80%
-0.60
アフターアワーズ：
15.13
-0.08
-0.53%
前日終値:
$15.81
開ける：
$15.7
24時間の取引高:
30,654
Relative Volume:
0.87
時価総額：
$96.68M
収益：
-
当期純損益:
$-61.23M
株価収益率:
-9.3313
EPS:
-1.63
ネットキャッシュフロー:
$22.49M
1週間 パフォーマンス:
-1.11%
1か月 パフォーマンス:
+1.26%
6か月 パフォーマンス:
-0.59%
1年 パフォーマンス:
+64.61%
1日の値動き範囲:
$15.00
$16.26
1週間の範囲:
$13.20
$16.75
52週間の値動き範囲:
$9.1032
$19.93
Assembly Biosciences Inc Stock (ASMB) Company Profile
名前
Assembly Biosciences Inc
セクター
電話
(833) 409-4583
住所
TWO TOWER PLACE, SOUTH SAN FRANCISCO
ASMB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
15.21 | 96.68M | 0 | -61.23M | 22.49M | -13.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-20 | アップグレード | Jefferies | Hold → Buy |
| 2021-09-13 | 開始されました | H.C. Wainwright | Neutral |
| 2021-09-02 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-03-23 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-11-06 | ダウングレード | Jefferies | Buy → Hold |
| 2020-10-19 | 開始されました | Truist | Buy |
| 2019-10-16 | 開始されました | Mizuho | Buy |
| 2018-11-19 | 開始されました | Leerink Partners | Outperform |
| 2018-10-08 | アップグレード | B. Riley FBR | Neutral → Buy |
| 2018-08-08 | 開始されました | Robert W. Baird | Outperform |
| 2018-04-13 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2018-01-05 | 開始されました | B. Riley FBR, Inc. | Neutral |
| 2017-11-08 | 開始されました | Jefferies | Buy |
| 2017-05-30 | 開始されました | Chardan Capital Markets | Buy |
すべてを表示
Assembly Biosciences Inc (ASMB) 最新ニュース
Assembly Biosciences (NASDAQ:ASMB) Stock Price Crosses Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
Gilead raises Assembly Bio stake to ~30% - MSN
Gilead invests in Assembly Bio to advance clinical programs - The Pharma Letter
Gilead boosts stake in Assembly Bio with $30.1 million investment By Investing.com - Investing.com Canada
Assembly Biosciences strikes amended deal with Gilead - Investing.com
Assembly Biosciences strikes amended deal with Gilead By Investing.com - Investing.com UK
Assembly Bio stock rises as Gilead ups stake (ASMB:NASDAQ) - Seeking Alpha
Assembly Biosciences Shares Rise 19% After Gilead Investment, Funding - MarketWatch
Assembly Biosciences Gets $30.1M Equity Investment, Funding From Gilead - MarketWatch
Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs - The Manila Times
Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from - The Bakersfield Californian
Assembly Bio Secures $30.1M Gilead Investment, Advancing Ambitious Antiviral Pipeline - StockTitan
(ASMB) Trading Advice - Stock Traders Daily
Assembly Biosciences, Inc. (NASDAQ:ASMB) Sees Significant Growth in Short Interest - MarketBeat
Reviewing BeiGene (NASDAQ:BGNE) and I-Mab (NASDAQ:IMAB) - Defense World
How the (ASMB) price action is used to our Advantage - Stock Traders Daily
Assembly Biosciences, Inc. (NASDAQ:ASMB) Sees Large Increase in Short Interest - MarketBeat
Assembly Biosciences investor Alexander Schornstein buys $372,994 in shares By Investing.com - Investing.com
Novavax and Assembly lead infectious disease gainers in 2024 - BioWorld Online
Comparing Cardiol Therapeutics (NASDAQ:CRDL) & Gilead Sciences (NASDAQ:GILD) - Defense World
Genome Editing Market Size Projected to Reach USD 32.72 - GlobeNewswire
Assembly Biosciences Reports Q3 2024 Financials and Strategic Advances - TipRanks
(ASMB) Pivots Trading Plans and Risk Controls - Stock Traders Daily
ARMISTICE CAPITAL, LLC Adjusts Stake in Assembly Biosciences Inc - GuruFocus.com
HC Wainwright Has Optimistic Outlook of ASMB FY2024 Earnings - MarketBeat
Assembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest Down 51.2% in October - MarketBeat
Analysts Just Slashed Their Assembly Biosciences, Inc. (NASDAQ:ASMB) EPS Numbers - Simply Wall St
Bearish: Analysts Just Cut Their Assembly Biosciences, Inc. (NASDAQ:ASMB) Revenue and EPS estimates - Yahoo Finance
Analyzing Taysha Gene Therapies (NASDAQ:TSHA) & Gilead Sciences (NASDAQ:GILD) - Defense World
Assembly Biosciences: Q3 Earnings Snapshot - CTPost
Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates - The Manila Times
Assembly Biosciences initiates at-the-market equity program - Investing.com India
Assembly Biosciences Inc (ASMB) Reports Q3 2024 Revenue of $6.8M, GAAP EPS Loss of $1.51, Misses Estimates - GuruFocus.com
Marquis Who's Who Honors Jonathan Colon, PhD, for Expertise in Biotechnology - 24-7 Press Release
Assembly Biosciences (NASDAQ:ASMB) Stock Crosses Above 200-Day Moving AverageShould You Sell? - MarketBeat
When (ASMB) Moves Investors should Listen - Stock Traders Daily
Baker Lab’s AI-Driven Antibody Cage Technology Unlocked as Archon Biosciences - Genetic Engineering & Biotechnology News
Short Interest in Assembly Biosciences, Inc. (NASDAQ:ASMB) Declines By 7.9% - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Share Price Crosses Above 200 Day Moving AverageHere's Why - MarketBeat
(ASMB) Investment Analysis and Advice - Stock Traders Daily
Microbiome Manufacturing Market Poised for Robust Growth at 15.4% CAGR by 2031 - WhaTech
Assembly Biosciences (NASDAQ:ASMB) Shares Pass Above 200-Day Moving AverageTime to Sell? - MarketBeat
Assembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest Update - MarketBeat
Assembly Biosciences, Inc.'s (NASDAQ:ASMB) market cap surged US$16m last week, individual investors who have a lot riding on the company were rewarded - Simply Wall St
Assembly Biosciences sees major stock purchase by investor Alexander Schornstein By Investing.com - Investing.com Canada
Alexander Schornstein Purchases 10,000 Shares of Assembly Biosciences, Inc. (NASDAQ:ASMB) Stock - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Share Price Crosses Above 200-Day Moving AverageTime to Sell? - MarketBeat
Assembly Biosciences CEO sells shares worth $2,917 to cover taxes By Investing.com - Investing.com South Africa
Assembly Biosciences Inc (ASMB) 財務データ
収益
当期純利益
現金流量
EPS
2.88%
2.65%
大文字化:
|
ボリューム (24 時間):